In 2002 Stephen Roth, who was about to retire as CEO of biotech Neose Technologies, sat down with two scientists from Drexel University to judge whether a new scientific concept made any sense.
In 2002 Stephen Roth, who was about to retire as CEO of biotech Neose Technologies, sat down with two scientists from Drexel University to judge whether a new scientific concept made any sense.
|
|||||||||
|
|||||||||
|